series-a
Stage
3
Investors
About
Glycotest develops non-invasive diagnostic tests based on glycan biomarkers to improve early disease detection and personalized patient care.
Explore Glycotest's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.